|
2016-12-05 |
2016-12-02 |
A
Achat
|
MADDALUNA ANTHONY J
Administrateur non-exécutif
|
1 518
+25.8%
16,46
24 986 USD
|
1 518
+25.8%
|
16,46
|
24 986 USD
|
|
|
2016-12-01 |
2016-11-30 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
9 000
-20.5%
16,71
150 390 USD
|
9 000
-20.5%
|
16,71
|
150 390 USD
|
|
|
2016-11-17 |
2016-11-16 |
V
Vente
|
HENDERSON LORI M.
SVP, Secretary & Gen Counsel
Dirigeant
|
6 000
-10.5%
17,00
102 000 USD
|
6 000
-10.5%
|
17,00
|
102 000 USD
|
|
|
2016-11-10 |
2016-11-10 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
785
-2.2%
16,79
13 180 USD
|
785
-2.2%
|
16,79
|
13 180 USD
|
|
|
2016-08-10 |
2016-08-09 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
1 401
-3.7%
15,29
21 421 USD
|
1 401
-3.7%
|
15,29
|
21 421 USD
|
|
|
2016-06-01 |
2016-05-31 |
V
Vente
|
OCONNOR KEVIN
Administrateur non-exécutif
|
5 000
-9.4%
14,41
72 050 USD
|
5 000
-9.4%
|
14,41
|
72 050 USD
|
|
|
2016-05-16 |
2016-05-16 |
A
Achat
|
Marth William S
President and CEO
Administrateur exécutif
|
12 500
+2.4%
12,86
160 750 USD
|
12 500
+2.4%
|
12,86
|
160 750 USD
|
|
|
2016-05-16 |
2016-05-13 |
A
Achat
|
Svokos George
Chief Operating Officer
Dirigeant
|
12 500
+13.0%
12,82
160 250 USD
|
12 500
+13.0%
|
12,82
|
160 250 USD
|
|
|
2016-05-16 |
2016-05-13 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
2 361
-5.9%
12,77
30 150 USD
|
2 361
-5.9%
|
12,77
|
30 150 USD
|
|
|
2015-11-10 |
2015-11-09 |
V
Vente
|
D AMBRA CONSTANCE M
Actionnaire important
|
50 000
-2.1%
19,60
980 000 USD
|
50 000
-2.1%
|
19,60
|
980 000 USD
|
|
|
2015-11-10 |
2015-11-09 |
V
Vente
|
D AMBRA THOMAS E
Chairman, Board of Directors
Administrateur non-exécutif
|
50 000
-2.0%
19,60
980 000 USD
|
50 000
-2.0%
|
19,60
|
980 000 USD
|
|
|
2015-08-17 |
2015-08-17 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
1 000
-3.4%
20,45
20 450 USD
|
1 000
-3.4%
|
20,45
|
20 450 USD
|
|
|
2015-08-10 |
2015-08-07 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
5 000
-14.8%
21,06
105 300 USD
|
5 000
-14.8%
|
21,06
|
105 300 USD
|
|
|
2015-06-09 |
2015-06-08 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
5 000
-14.8%
19,99
99 950 USD
|
5 000
-14.8%
|
19,99
|
99 950 USD
|
|
|
2015-06-08 |
2015-06-04 |
A
Achat
|
Marth William S
President and CEO
Administrateur exécutif
|
10 000
+2.3%
19,98
199 800 USD
|
10 000
+2.3%
|
19,98
|
199 800 USD
|
|
|
2015-06-05 |
2015-06-04 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
787
-2.7%
19,58
15 409 USD
|
787
-2.7%
|
19,58
|
15 409 USD
|
|
|
2015-06-04 |
2015-06-02 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
3 750
-11.3%
19,39
72 713 USD
|
3 750
-11.3%
|
19,39
|
72 713 USD
|
|
|
2015-05-11 |
2015-05-08 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
7 500
-19.4%
19,20
144 000 USD
|
7 500
-19.4%
|
19,20
|
144 000 USD
|
|
|
2015-05-11 |
2015-05-08 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
7 000
-18.3%
19,35
135 450 USD
|
7 000
-18.3%
|
19,35
|
135 450 USD
|
|
|
2015-03-19 |
2015-03-17 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
3 500
-11.2%
18,53
64 855 USD
|
3 500
-11.2%
|
18,53
|
64 855 USD
|
|
|
2015-03-16 |
2015-03-13 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
441
-1.4%
18,79
8 286 USD
|
441
-1.4%
|
18,79
|
8 286 USD
|
|
|
2015-03-13 |
2015-03-12 |
V
Vente
|
OCONNOR KEVIN
Administrateur non-exécutif
|
5 000
-10.4%
18,22
91 100 USD
|
5 000
-10.4%
|
18,22
|
91 100 USD
|
|
|
2015-03-13 |
2015-03-12 |
V
Vente
|
ROTH ARTHUR J
Administrateur non-exécutif
|
5 000
-11.2%
18,26
91 300 USD
|
5 000
-11.2%
|
18,26
|
91 300 USD
|
|
|
2015-03-12 |
2015-03-11 |
V
Vente
|
Hagen Steven R
SVP Manufacturing & Pharmaceut
Dirigeant
|
721
-2.2%
18,30
13 194 USD
|
721
-2.2%
|
18,30
|
13 194 USD
|
|
|
2015-03-11 |
2015-03-10 |
A
Achat
|
Svokos George
Chief Commercial Officer
Dirigeant
|
10 000
+16.5%
17,72
177 200 USD
|
10 000
+16.5%
|
17,72
|
177 200 USD
|
|
|
2015-03-06 |
2015-03-05 |
A
Achat
|
Marth William S
President and CEO
Administrateur exécutif
|
20 000
+5.1%
17,70
354 000 USD
|
20 000
+5.1%
|
17,70
|
354 000 USD
|
|
|
2015-02-27 |
2015-02-25 |
V
Vente
|
Nolan Michael M
CFO
Dirigeant
|
5 000
-6.8%
16,17
80 850 USD
|
5 000
-6.8%
|
16,17
|
80 850 USD
|
|
|
2015-02-25 |
2015-02-23 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
3 750
-13.0%
16,22
60 825 USD
|
3 750
-13.0%
|
16,22
|
60 825 USD
|
|
|
2015-02-20 |
2015-02-18 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
1 250
-4.7%
16,46
20 575 USD
|
1 250
-4.7%
|
16,46
|
20 575 USD
|
|
|
2015-02-20 |
2015-02-18 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
3 750
-13.0%
16,60
62 250 USD
|
3 750
-13.0%
|
16,60
|
62 250 USD
|
|
|
2015-02-20 |
2015-02-18 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
1 623
-6.1%
16,48
26 747 USD
|
1 623
-6.1%
|
16,48
|
26 747 USD
|
|
|
2014-12-05 |
2014-12-04 |
VP
Vente planifiée
|
CABLE STUART M
Actionnaire important
|
10 391
-0.3%
16,00
166 262 USD
|
10 391
-0.3%
|
16,00
|
166 262 USD
|
|
|
2014-11-18 |
2014-11-14 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
10 500
-25.3%
16,06
168 630 USD
|
10 500
-25.3%
|
16,06
|
168 630 USD
|
|
|
2014-11-12 |
2014-11-10 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
7 500
-19.5%
17,03
127 725 USD
|
7 500
-19.5%
|
17,03
|
127 725 USD
|
|
|
2014-11-10 |
2014-11-10 |
A
Achat
|
Marth William S
President and CEO
Administrateur exécutif
|
30 000
+9.6%
17,01
510 300 USD
|
30 000
+9.6%
|
17,01
|
510 300 USD
|
|
|
2014-09-02 |
2014-08-28 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
1 250
-3.9%
19,74
24 675 USD
|
1 250
-3.9%
|
19,74
|
24 675 USD
|
|
|
2014-08-14 |
2014-08-14 |
V
Vente
|
Nolan Michael M
SVP, CFO and Treasurer
Dirigeant
|
10 000
-11.6%
19,76
197 600 USD
|
10 000
-11.6%
|
19,76
|
197 600 USD
|
|
|
2014-08-13 |
2014-08-12 |
V
Vente
|
HENDERSON LORI M
SVP, Secretary & Gen. Counsel
Dirigeant
|
30 000
-40.2%
19,05
571 500 USD
|
30 000
-40.2%
|
19,05
|
571 500 USD
|
|
|
2014-08-12 |
2014-08-08 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
10 000
-24.4%
18,99
189 900 USD
|
10 000
-24.4%
|
18,99
|
189 900 USD
|
|
|
2014-08-12 |
2014-08-08 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
797
-2.5%
18,99
15 135 USD
|
797
-2.5%
|
18,99
|
15 135 USD
|
|
|
2014-06-04 |
2014-06-03 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
2 500
-7.3%
16,93
42 325 USD
|
2 500
-7.3%
|
16,93
|
42 325 USD
|
|
|
2014-05-20 |
2014-05-16 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
1 250
-3.6%
15,45
19 313 USD
|
1 250
-3.6%
|
15,45
|
19 313 USD
|
|
|
2014-05-16 |
2014-05-15 |
A
Achat
|
Svokos George
SVP Sales & GM of API
Dirigeant
|
10 000
+22.4%
15,60
156 000 USD
|
10 000
+22.4%
|
15,60
|
156 000 USD
|
|
|
2014-05-13 |
2014-05-12 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
2 500
-7.0%
15,27
38 175 USD
|
2 500
-7.0%
|
15,27
|
38 175 USD
|
|
|
2014-05-13 |
2014-05-12 |
A
Achat
|
Marth William S
President and CEO
Administrateur exécutif
|
30 000
+10.6%
15,40
462 000 USD
|
30 000
+10.6%
|
15,40
|
462 000 USD
|
|
|
2014-05-13 |
2014-05-09 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
2 500
-7.0%
14,80
37 000 USD
|
2 500
-7.0%
|
14,80
|
37 000 USD
|
|
|
2014-05-13 |
2014-05-09 |
V
Vente
|
Hagen Steven R
SVP Pharmaceutical Dev & Mfg
Dirigeant
|
897
-2.6%
14,80
13 276 USD
|
897
-2.6%
|
14,80
|
13 276 USD
|
|
|
2014-02-28 |
2014-02-27 |
V
Vente
|
ROTH ARTHUR J
Administrateur non-exécutif
|
5 000
-11.9%
15,95
79 750 USD
|
5 000
-11.9%
|
15,95
|
79 750 USD
|
|
|
2014-02-27 |
2014-02-27 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
3 000
-7.9%
15,73
47 190 USD
|
3 000
-7.9%
|
15,73
|
47 190 USD
|
|
|
2014-02-25 |
2014-02-25 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
2 500
-6.7%
15,19
37 975 USD
|
2 500
-6.7%
|
15,19
|
37 975 USD
|
|
|
2014-02-25 |
2014-02-24 |
V
Vente
|
Nolan Michael M
VP, CFO and Treasurer
Dirigeant
|
15 000
-16.5%
15,00
225 000 USD
|
15 000
-16.5%
|
15,00
|
225 000 USD
|
|
|
2014-02-24 |
2014-02-21 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
1 500
-4.1%
14,87
22 305 USD
|
1 500
-4.1%
|
14,87
|
22 305 USD
|
|
|
2014-02-19 |
2014-02-19 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
1 500
-4.0%
13,37
20 055 USD
|
1 500
-4.0%
|
13,37
|
20 055 USD
|
|
|
2013-12-04 |
2013-12-04 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
2 500
-8.4%
10,93
27 325 USD
|
2 500
-8.4%
|
10,93
|
27 325 USD
|
|
|
2013-12-04 |
2013-12-03 |
A
Achat
|
Marth William S
Administrateur non-exécutif
|
30 000
+49.1%
10,75
322 500 USD
|
30 000
+49.1%
|
10,75
|
322 500 USD
|
|
|
2013-11-22 |
2013-11-22 |
A
Achat
|
Marth William S
Administrateur non-exécutif
|
20 000
+48.6%
11,57
231 400 USD
|
20 000
+48.6%
|
11,57
|
231 400 USD
|
|
|
2013-11-22 |
2013-11-22 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
2 300
-7.7%
11,55
26 565 USD
|
2 300
-7.7%
|
11,55
|
26 565 USD
|
|
|
2013-06-04 |
2013-06-03 |
A
Achat
|
Marth William S
Administrateur non-exécutif
|
10 000
+35.3%
10,23
102 300 USD
|
10 000
+35.3%
|
10,23
|
102 300 USD
|
|
|
2013-05-31 |
2013-05-29 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
800
-2.5%
11,26
9 008 USD
|
800
-2.5%
|
11,26
|
9 008 USD
|
|
|
2013-05-23 |
2013-05-22 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
7 500
-11.6%
10,97
82 275 USD
|
7 500
-11.6%
|
10,97
|
82 275 USD
|
|
|
2013-05-13 |
2013-05-10 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
1 200
-3.6%
10,40
12 480 USD
|
1 200
-3.6%
|
10,40
|
12 480 USD
|
|
|
2013-03-20 |
2013-03-19 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
258
-0.4%
9,91
2 557 USD
|
258
-0.4%
|
9,91
|
2 557 USD
|
|
|
2013-03-20 |
2013-03-19 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
180
-0.5%
9,91
1 784 USD
|
180
-0.5%
|
9,91
|
1 784 USD
|
|
|
2013-03-20 |
2013-03-18 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
256
-0.4%
9,98
2 555 USD
|
256
-0.4%
|
9,98
|
2 555 USD
|
|
|
2013-03-20 |
2013-03-18 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
249
-0.7%
9,98
2 485 USD
|
249
-0.7%
|
9,98
|
2 485 USD
|
|
|
2013-03-13 |
2013-03-13 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
852
-1.5%
10,69
9 108 USD
|
852
-1.5%
|
10,69
|
9 108 USD
|
|
|
2013-03-14 |
2013-03-12 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
677
-1.9%
10,75
7 278 USD
|
677
-1.9%
|
10,75
|
7 278 USD
|
|
|
2013-03-13 |
2013-03-12 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
694
-1.2%
10,75
7 461 USD
|
694
-1.2%
|
10,75
|
7 461 USD
|
|
|
2013-03-13 |
2013-03-12 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
1 070
-1.8%
10,73
11 481 USD
|
1 070
-1.8%
|
10,73
|
11 481 USD
|
|
|
2013-03-13 |
2013-03-11 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
3 538
-5.5%
10,25
36 265 USD
|
3 538
-5.5%
|
10,25
|
36 265 USD
|
|
|
2013-03-11 |
2013-03-07 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
1 000
-2.8%
9,56
9 560 USD
|
1 000
-2.8%
|
9,56
|
9 560 USD
|
|
|
2013-02-26 |
2013-02-22 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
984
-2.7%
8,18
8 049 USD
|
984
-2.7%
|
8,18
|
8 049 USD
|
|
|
2013-02-26 |
2013-02-22 |
V
Vente
|
Sargent Bruce J
Sr VP, Drug Discovery
Dirigeant
|
984
-1.5%
8,18
8 049 USD
|
984
-1.5%
|
8,18
|
8 049 USD
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Hagen Steven R
Sr VP Pharmaceutical Dev & Mfg
Dirigeant
|
1 000
-2.6%
7,89
7 890 USD
|
1 000
-2.6%
|
7,89
|
7 890 USD
|
|
|
2012-12-04 |
2012-12-03 |
A
Achat
|
Marth William S
Administrateur non-exécutif
|
10 000
+80.3%
5,00
50 000 USD
|
10 000
+80.3%
|
5,00
|
50 000 USD
|
|
